United Therapeutics

United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy

United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy

Seeking Alpha

Biotechs Near Highs In A Week Of Key Earnings Reports

Biotechs Near Highs In A Week Of Key Earnings Reports

Investors.com

FDA rejects United Therapeutics' oral hypertension drug again

FDA rejects United Therapeutics' oral hypertension drug again

Reuters

4 Key Drug Approvals Expected In The Next 30 Days

4 Key Drug Approvals Expected In The Next 30 Days

investors.com

Best And Worst FDA Drug Approval Stocks of 2013

Best And Worst FDA Drug Approval Stocks of 2013

TheStreet.com

United Therapeutics 4Q profit jumps 93 percent

United Therapeutics 4Q profit jumps 93 percent

Yahoo/AP

2 Fast Growing Biotech Stocks With Recent Insider Buying

2 Fast Growing Biotech Stocks With Recent Insider Buying

Seeking Alpha

This Biotech Is Opportunistic With Recent CEO Buys

This Biotech Is Opportunistic With Recent CEO Buys

Motley Fool

United Therapeutics

This Week in Biotech

This Week in Biotech

Motley Fool

United Therapeutics Falls as FDA Rejects Oral Remodulin

United Therapeutics Falls as FDA Rejects Oral Remodulin

Bloomberg